Navigation Links
Reportlinker Adds Biomarkers: Technologies and Global Markets
Date:5/3/2011

troduce products during the forecast period and discusses how these introductions will change the face of the competitive environment. The competitive environment is examined with a special focus on how new products and technologies are influencing the current standard of care. Detailed profiles of current market leaders are discussed, as well as companies with innovative products poised to advance within the forecast period.

Market figures are based on revenues at the manufacturers' level and are projected at 2010-dollar value. Inflation is not computed into the projection figures. Trends are assessed based on projected sales for existing products, new product introductions, expanded indications for existing products, and projected changes in the prevalence, diagnosis, and scripting rates for certain diseases.

Included in this report are forecasts by product, product category, and by company from 2009 through 2015. The study is arranged to offer an overview of the biomarkers market accompanied by product, company, geography, and mechanism of action with forecasts broken down and covered by geographic region or country. Virtually the entire globe is covered to include prevalence data, for each disease subsegment.

Excluded from this report are over-the-counter (OTC) medications, and other consumables that do not require a physician's prescription.

Sales figures are reported in U.S. dollars and in each case reflect currency fluctuations within the performance of revenue change. Revenue figures do not account for variation in local currencies.

All market share data presented is on a global basis, unless specifically noted.

INTENDED AUDIENCE

This report is an invaluable tool for business planners, acquisitions specialists, licensing strategists, product managers, market research analysts, investors, investor consultants and anyone interested in the biomarkers market, its products, its industry participants, and its futu
'/>"/>

SOURCE MDX
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Reportlinker Adds Medical Enzymes: Technologies and Global Markets
2. Reportlinker Adds Case Study: Personalized Cancer Therapy - The era of biomarker identification and companion diagnostic co-development
3. Reportlinker Adds R&D Trends: Osteoporosis - Strong pipeline bodes well for future treatment
4. Reportlinker Adds Molecular Diagnostics Market: DNA Probes And Biochips
5. Reportlinker Adds Competitor Analysis: Targeted Therapy of Diabetes
6. Reportlinker Adds China Bio-breeding Industry Report, 2010
7. Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other
8. Reportlinker Adds Biomarker Partnering Terms and Agreements
9. Reportlinker Adds Top & Emerging Bio-Fuel Markets by Technology, Feedstocks, Regulations, Pricing & Commercialization Trends & Forecasts (2011 - 2016)
10. Reportlinker Adds Industrial Biotechnology China News 1103
11. Reportlinker Adds DNA Sequencing - Technologies, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... GEA Pharma Systems, G-CON Manufacturing ... of the INTERPHEX Exhibitor Awards for 2015 for ... Continuous, Miniature and Modular (PCMM) platform. PCMM comprises ... processing equipment, smart control systems and PODs (portable, ... inactive ingredients into bulk tablets. , PCMM ...
(Date:5/4/2015)... , May 4, 2015 Many ... granted. But for certain infants with rare, inherited ... are stark consequences of their impaired immune responses. ... Center have identified an important role for calcium ... from Mycobacterium tuberculosis, the bacterium causing tuberculosis (TB). ...
(Date:5/4/2015)... 2015 GliaCure, a privately-held biotechnology company ... neurological and neuropsychiatric disorders based on glial targets, ... patients in a Phase 1b clinical trial of ... as a potential disease-modifying treatment. GliaCure,s innovative approach ... it both promotes the clearance of amyloid and ...
(Date:5/4/2015)... May 4, 2015 /PRNewswire/ - The Fight Against ... pleased to announce the formation of Turnstone Biologics ... treatments for cancer that harness the patient,s own ... unique collaboration between the Children,s Hospital of ... McMaster University, the Ontario Institute for Cancer Research ...
Breaking Biology Technology:GEA Pharma Systems, G-CON Manufacturing and Pfizer Consortium Receives Best Technology Innovation Award at INTERPHEX 2015 2GEA Pharma Systems, G-CON Manufacturing and Pfizer Consortium Receives Best Technology Innovation Award at INTERPHEX 2015 3Researchers Discover A Novel And Unexpected Role For Calcium In Controlling Inflammation During Chronic Lung Infection 2Researchers Discover A Novel And Unexpected Role For Calcium In Controlling Inflammation During Chronic Lung Infection 3GliaCure Initiates Phase 1b Dosing in Alzheimer's Patients 2Turnstone Biologics Inc. to accelerate clinical and commercial translation of cancer immunotherapies 2Turnstone Biologics Inc. to accelerate clinical and commercial translation of cancer immunotherapies 3
... Feb. 12 AdvanDx announced it has named,Else ... Dako A/S, as Vice,President of Sales and Marketing. ... AdvanDx,s fast, accurate and easy-to-use in vitro,molecular diagnostic ... infectious pathogens. Ms. Trautner previously managed an,organization of ...
... /PRNewswire-FirstCall/ - AEterna Zentaris Inc.,(NASDAQ: AEZS ; ... therapy and oncology, today reported that dosing of ... doxorubicin,has commenced in its Phase 2 trial in ... December 2007. This open-label,non-comparative multi-center Phase 2 trial ...
... Lasers to be Exclusively Featured in Leading Dental Education ... ... HOYA ConBio(TM), a global,leader in dental and aesthetic lasers, ... recognized dental education,company, in which VersaWave(TM) and DioDent(TM) Micro 980 ...
Cached Biology Technology:Molecular Diagnostics Leader AdvanDx Taps Former Dako Executive Vice President to Lead Global Sales and Marketing Expansion 2AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers 2AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers 3AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers 4HOYA ConBio and The Hornbrook Group Announce Expanded Alliance 2HOYA ConBio and The Hornbrook Group Announce Expanded Alliance 3
(Date:4/14/2015)... , April 14, 2015 NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... nominated for the 2015 New York Design Awards under ... Design100, New York City Design Awards are part of ... on over 2,500 ratings from the marketplace, industry and ...
(Date:4/8/2015)... N.C. , April 8, 2015  Infinisource, ... solutions and services, and Morpho, a leading supplier ... partnership to produce the market,s most advanced biometrically-enabled ... Infinisource,s iSolved NXG time clock is setting a ... and labor data for the small and mid-size ...
(Date:4/2/2015)... Sweden , April 2, 2015 ... its touch fingerprint sensor FPC1025 from the distributor World ... will commence during Q2 2015 although the major part ... The sensors will be used by smartphone manufacturers in ... 110 MSEK is included in the communicated revenue guidance ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2
... Mayor Jerry Sanders today joined UC San Diego Chancellor ... announce their support for a regional partnership designed to ... Speaking at a news conference on the UC San ... Diego region, now home to more than 500 biotechnology ...
... in U.S. dollars have been awarded to Singapore ... related to asthma and other immune system disorders, ... grants were awarded by the Biomedical Research Council ... Research), the government agency driving Singapore,s transformation into ...
... Ohio Very few athletic trainers associated with National ... following best practice standards for managing asthma among their ... with asthma, the dangers of the condition can be ... to be incapacitating, or deadly. The lead report is ...
Cached Biology News:Regional partnership to develop algal biofuels gets backing of San Diego leaders 2Regional partnership to develop algal biofuels gets backing of San Diego leaders 3Regional partnership to develop algal biofuels gets backing of San Diego leaders 4Regional partnership to develop algal biofuels gets backing of San Diego leaders 5Regional partnership to develop algal biofuels gets backing of San Diego leaders 6Alzheimer's, asthma, cancer, malaria and TB focus of new Singapore grants 2Alzheimer's, asthma, cancer, malaria and TB focus of new Singapore grants 3Alzheimer's, asthma, cancer, malaria and TB focus of new Singapore grants 4Athletes with asthma need more help from their team trainers 2
Rabbit polyclonal to VPAC2 ( Abpromise for all tested applications). entrezGeneID: 7434 SwissProtID: P41587...
Mouse Anti-Human Methyl-CpG binding domain protein 2 (MBD2 Monoclonal Antibody Family: Other Applications: Western Blot...
... The 2/3D Waver Shaker combines shaking and ... with a 330 x 330 mm stainless steel ... top incubator and cold room operation. The platform ... degree for a vigorous with action and rotation ...
...
Biology Products: